The Kowalinski group at EMBL Grenoble discovered notable differences between the nuclear cap-binding complex in trypanosomes and humans, a critical component in cellular RNA metabolism. Trypanosomes ...

Ranjan Narula, Swati Dalal, and Vanshika Oberoi of RNA, Technology and IP Attorneys explore the legal framework, challenges, ...

The highly anticipated 2025 ASC Student Supercomputer Challenge (ASC25) launch event was held recently in Beijing. The ...

JERUSALEM - Israeli scientists have discovered a unique genetic mechanism that provides human cells with efficient protection ...

Researchers at the University of Copenhagen and NTU Singapore have discovered that RNA damage, not DNA damage, is the real trigger for the acute effects of sunburn. This new understanding challenges ...

Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent and tissue-targeted medicines, today announced the dosing of the first patient in its clinical trial of ABX1100, a ...

The Phase Ib trial is set to test a gene therapy designed to target a rare disorder that causes muscle and respiratory failure.

MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to ...

中新网1月24日电据路透社消息，当地时间23日，美国总统特朗普签署了一项行政令，将解密有关美国前总统约翰·肯尼迪、前参议员罗伯特·肯尼迪以及民权领袖马丁·路德·金遇刺案的相关机密文件。

Bioinformatics allowed me to address these questions faster and with a broader perspective. The growing availability of public data facilitated this. However, the transition wasn’t easy. I tried many ...

Exicure announced the acquisition of GPCR Therapeutics USA Inc. (GPCR USA), a significant step that could reshape the company’s future. Under the terms of the agreement, Exicure acquired all the ...

Serum Institute of India is planning to introduce chikungunya and monkeypox vaccines in about a year and a half and a dengue vaccine in approximately three years. The company is focusing on vaccine ...